HIV & AIDS

AIDS—an approach for targeting HIV reservoirs

Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics ...

HIV & AIDS

New insights into HIV latent cells yield potential cure targets

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators ...

HIV & AIDS

Existing drugs may limit damage caused by HIV

Yale researchers have identified four drugs that may help minimize the long-term health effects of HIV infection, they report June 23 in the Journal of Clinical Investigation.

HIV & AIDS

'Mississippi Baby' now has detectable HIV, researchers find

The child known as the "Mississippi baby"—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable ...

HIV & AIDS

Advancing the long-term well-being of people living with HIV

Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite ...

Medical research

Dormant viral genes may awaken to cause ALS

Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons in some forms of amyotrophic lateral sclerosis (ALS). The ...

HIV & AIDS

Novel antibody may suppress HIV for up to four months

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) ...

HIV & AIDS

10-year lifespan gain for some HIV patients: study

The life expectancy of HIV-infected people in Europe and the United States has been boosted by a decade since anti-AIDS drugs became available in the mid-1990s, researchers said Thursday.

page 10 from 40